Lupus

Top Story

Less than 2% of infusions for pediatric rheumatic diseases result in adverse events

Less than 2% of infusions for pediatric rheumatic diseases result in adverse events
April 11, 2018
In the Journals

Gene variant linked to lupus more prevalent among Kuwaiti patients

April 11, 2018
Patients from Kuwait with systemic lupus erythematosus demonstrated a relatively high 17.4% frequency of the protein tyrosine phosphatase non-receptor type 22 gene…
In the JournalsPerspective

Blisibimod linked to steroid reduction, decreased proteinuria in patients with lupus

April 10, 2018
Although blisibimod did not meet its primary-endpoint response rate in a phase 3 study of patients with systemic lupus erythematosus, the investigational agent was…
FDA News

FDA declines proposed Rituxan, Herceptin biosimilars from Celltrion

April 6, 2018
The FDA has rejected approval of Celltrion’s biologics license applications for Truxima, a proposed rituximab biosimilar, and Herzuma, a proposed trastuzumab…
More Headlines »
CME ABIM MOC

Ace the Case: 60-Year-Old Woman with Recurrent Infections and Bronchitis

There is no commercial support for this activity.

This “Ace the Case” study will explore the diagnosis and management of an adult woman with recurrent infections and…
More »
Video
Meeting News Coverage

VIDEO: Use of checkpoint inhibitors has advanced the treatment of cancer

August 5, 2016
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME

Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management

This activity is supported by an educational grant from Bristol-Myers Squibb.

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new…
More »